Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026

Héloïse Lucaccioni, the European IVE group(Collaborative Neuroscience Network), Hanne‐Dorthe Emborg(Statens Serum Institut), Karina Lauenborg Møller, Magda Bucholc(University of Ulster), Esther Kissling, Suzanne Wilton(Public Health Agency), Freja Kirsebom(UK Health Security Agency), Safraj Shahul Hameed(Sultan Qaboos University), Kirsty Morrison(Public Health Scotland), Mark G. O’Doherty(Public Health Agency), Nick Andrews(Environment Agency), Jamie Lopez-Bernal(UK Health Security Agency), Mark Hamilton(Public Health Scotland), Francisco Pozo(Instituto de Salud Carlos III), Ramona Trebbien(Statens Serum Institut), Diogo F.P. Marques, Angela MC Rose, Amanda Bolt Botnen(Statens Serum Institut), Simon Cottrell(Public Health Wales), Heather Whitaker(Public Health Agency of Canada)
Eurosurveillance
February 19, 2026
Cited by 7


Related Papers